Sanofi
SNY
757 hedge funds and large institutions have $10.8B invested in Sanofi in 2025 Q4 according to their latest regulatory filings, with 122 funds opening new positions, 248 increasing their positions, 262 reducing their positions, and 62 closing their positions.
97% more first-time investments, than exits
New positions opened: 122 | Existing positions closed: 62
6% more funds holding
Funds holding: 712 → 757 (+45)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
0.6% less ownership
Funds ownership: 9.68% → 9.08% (-0.6%)
4% less capital invested
Capital invested by funds: $11.2B → $10.8B (-$416M)
5% less repeat investments, than reductions
Existing positions increased: 248 | Existing positions reduced: 262
38% less call options, than puts
Call options by funds: $99.3M | Put options by funds: $160M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$81.8M |
| 2 |
Morgan Stanley
New York
|
+$76.4M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$57.9M |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$50.7M |
| 5 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
+$42.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
-$617M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$149M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
-$76.3M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$65.9M |
| 5 |
Millennium Management
New York
|
-$64.3M |
SNY Hedge Fund Activity: Q4 2025 in Review
757 of the 8,265 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q4 2025, worth a combined $10.8B — down 3.7% from $11.2B a quarter earlier.
Buyers outnumbered sellers: 122 funds opened new SNY positions and 62 closed out — a net gain of 60 holders — while 248 added to existing stakes and 262 trimmed.
The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $81.8M. The largest seller was Dodge & Cox, cutting an estimated $617M.
- 757 institutional investors held Sanofi (SNY) as of Q4 2025, up from 712 in Q3 2025.
- Funds reported $10.8B of Sanofi stock for Q4 2025, down 3.7% quarter-over-quarter.
- 122 funds opened new Sanofi positions in Q4 2025 and 62 closed out, a net change of +60 holders.
- The largest Sanofi buyer in Q4 2025 was Capital Research Global Investors, an estimated $81.8M added.
- The largest Sanofi seller in Q4 2025 was Dodge & Cox, an estimated $617M sold.
Based on aggregated 13F filings for Q4 2025.